SecBot SecBot
SECBOTREPLAY Home › Report › NBIX

NBIX · Director George J

NEUROCRINE BIOSCIENCES INC · 144 filed Oct 30, 2026 at 16:20 ET

At the news

NEUTRALIMPACT 1/10

144 filed Oct 30, 2026 at 16:20 ET

Director George J. Morrow filed a Form 144 notice of intent to sell 300 shares of Neurocrine Biosciences common stock, valued at approximately $43,914 based on the filing date. The shares were acquired through option exercise on the same date. The proposed sale is very small relative to the company's $14.8B market cap and represents a routine insider transaction.

  • Director George J. Morrow filed Form 144 to sell 300 shares of NBIX common stock.
  • Estimated value of proposed sale: $43,914 (based on filing date).
  • Shares were acquired via option exercise on 10/30/2026.
  • Sale is immaterial relative to NBIX's $14.8B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access